Differential sensitivity of murine leukemia virus to APOBEC3-mediated inhibition is governed by virion exclusion.
about
Human retroviral host restriction factors APOBEC3G and APOBEC3F localize to mRNA processing bodiesAdaptive evolution and antiviral activity of the conserved mammalian cytidine deaminase APOBEC3H.APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cellsRole and mechanism of action of the APOBEC3 family of antiretroviral resistance factorsA single amino acid difference in human APOBEC3H variants determines HIV-1 Vif sensitivityIdentification of APOBEC3DE as another antiretroviral factor from the human APOBEC familyIdentification of amino acid residues in APOBEC3G required for regulation by human immunodeficiency virus type 1 Vif and Virion encapsidationMultiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them allThe APOBEC3 family of retroelement restriction factorsEvidence and controversies on the role of XMRV in prostate cancer and chronic fatigue syndromeNewly synthesized APOBEC3G is incorporated into HIV virions, inhibited by HIV RNA, and subsequently activated by RNase HIntrinsic immunity against retrotransposons by APOBEC cytidine deaminasesAn ancient history of gene duplications, fusions and losses in the evolution of APOBEC3 mutators in mammalsAPOBEC3G: an intracellular centurionRole of APOBEC3 in genetic diversity among endogenous murine leukemia virusesCellular inhibitors of long interspersed element 1 and Alu retrotransposition.Vpr14-88-Apobec3G fusion protein is efficiently incorporated into Vif-positive HIV-1 particles and inhibits viral infection.Are viruses inhibited by APOBEC3 molecules from their host species?Apobec 3G efficiently reduces infectivity of the human exogenous gammaretrovirus XMRVLeveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS.Host restriction of murine gammaherpesvirus 68 replication by human APOBEC3 cytidine deaminases but not murine APOBEC3.Susceptibility of xenotropic murine leukemia virus-related virus (XMRV) to retroviral restriction factors.Incorporation of mouse APOBEC3 into murine leukemia virus virions decreases the activity and fidelity of reverse transcriptase.Inhibition of xenotropic murine leukemia virus-related virus by APOBEC3 proteins and antiviral drugs.APOBEC3A is a specific inhibitor of the early phases of HIV-1 infection in myeloid cells.Long-term restriction by APOBEC3F selects human immunodeficiency virus type 1 variants with restored Vif functionThe glycosylated Gag protein of a murine leukemia virus inhibits the antiretroviral function of APOBEC3.APOBEC3 proteins expressed in mammary epithelial cells are packaged into retroviruses and can restrict transmission of milk-borne virionsHuman APOBEC3 proteins can inhibit xenotropic murine leukemia virus-related virus infectivity.The role of amino-terminal sequences in cellular localization and antiviral activity of APOBEC3B.Resistance of human T cell leukemia virus type 1 to APOBEC3G restriction is mediated by elements in nucleocapsidAPOBEC3G levels predict rates of progression to AIDSAPOBEC3 versus Retroviruses, Immunity versus Invasion: Clash of the Titans.A novel role for APOBEC3: susceptibility to sexual transmission of murine acquired immunodeficiency virus (mAIDS) is aggravated in APOBEC3 deficient mice.Retroelements versus APOBEC3 family members: No great escape from the magnificent sevenDNA cytosine and methylcytosine deamination by APOBEC3B: enhancing methylcytosine deamination by engineering APOBEC3B.Enzymatically active APOBEC3G is required for efficient inhibition of human immunodeficiency virus type 1.Inhibition of alpharetrovirus replication by a range of human APOBEC3 proteinsAPOBEC3 cytidine deaminases: distinct antiviral actions along the retroviral life cycle.Species-specific restriction of apobec3-mediated hypermutation.
P2860
Q21090536-7E7D9729-E506-43F7-99C4-D52258E40273Q24311896-E75A3B5D-C032-45A0-ACB7-0F044E1FDA65Q24536003-88F31A82-61D2-413D-AC63-5E92CC419F54Q24537623-7C7FA8E4-C2E2-41FF-A011-C630A2D2607AQ24656551-E307C520-8A95-410B-AA4E-CC8523A14D5EQ24670173-FE986F6F-C71B-4BAB-9D27-DC9C80D3B3BEQ24672209-3C60FE31-2DF3-4641-87DA-80800F0E0035Q26823568-93F74D4F-80A3-4E1D-AC52-264DA85C301CQ26862780-88343BA3-2D14-4295-83C1-FA8B3BD49931Q28304673-6E8FF637-92F5-49EE-A3DD-4810DCA0BCAFQ28469134-1B802A0A-EF25-43EB-95CB-FB06360DBAE5Q28708757-2069CDE8-B313-4508-87D2-0CE66620FA33Q28713968-D30E5EEB-B5F6-4C9A-A95F-D3ADFAA07D76Q28754989-0C08C838-7A15-449D-9B95-27A0CEC8D902Q28756829-B63D8C60-998E-4794-9501-30F4FBB4D439Q30445599-F42EC176-E2AF-49A0-85D7-928AB2BF472BQ33328499-4FCE07F7-543A-4E07-AAB8-7CE40EE9C627Q33434458-8E1068F5-2971-41C0-B411-FF72C2CF49F3Q33644321-2F7B238D-D958-412B-B5D1-F3AD48EB4B7CQ33654949-4E15968B-1675-4976-84A7-E19171FFCA75Q33677823-5E7E59C9-EE70-404A-AF82-C74C8E0535F6Q33740120-5BAC241B-06FF-4997-9DC8-FFF50AAB1AB9Q33744029-049D43D1-5C1D-4813-92DD-746C1B752250Q33877299-EAAADD61-E63A-45A6-ACE5-CC5657639277Q34037651-FF06AB70-25F8-43C2-8161-C30031A8733DQ34120768-108F8EBE-DBCC-4C34-8B04-89AD21C38FCAQ34178169-D1ECC370-C311-4B14-97B9-33607A239017Q34505004-15AD8E94-2BA1-46F0-85C1-72DD5C657760Q34558286-A76CB66E-4E97-40E1-8539-CBC8A15CAAEEQ35192821-D87FE9F9-0A5F-43C6-A38B-7B4C6B814BAEQ35669808-C996A704-A9C9-416A-B153-8B1FD0C994DEQ35699707-BDE7879A-9B07-43F7-AACF-229A08657501Q36031782-4F718E11-5DE6-42F2-85DE-3B062732805FQ36161438-D51D54DB-666A-494E-A670-52CFFE1296D9Q36162443-B223BB76-2F78-48E7-BD0E-3E08E2AF8850Q36184715-48755C2A-2579-4F82-9F4B-47F81CBCE0F6Q36315163-D3249551-0E73-450B-804B-E2D37A6D84FAQ36315179-A421E948-7EA3-4641-8E53-18C6622CB489Q36366147-0DA85707-C1EE-473D-897F-391D8F8AEC12Q36424190-BD67D045-7162-4AD1-9D9F-181D1056880F
P2860
Differential sensitivity of murine leukemia virus to APOBEC3-mediated inhibition is governed by virion exclusion.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Differential sensitivity of mu ...... s governed by virion exclusion
@nl
Differential sensitivity of mu ...... governed by virion exclusion.
@ast
Differential sensitivity of mu ...... governed by virion exclusion.
@en
Differential sensitivity of mu ...... governed by virion exclusion.
@en-gb
type
label
Differential sensitivity of mu ...... s governed by virion exclusion
@nl
Differential sensitivity of mu ...... governed by virion exclusion.
@ast
Differential sensitivity of mu ...... governed by virion exclusion.
@en
Differential sensitivity of mu ...... governed by virion exclusion.
@en-gb
prefLabel
Differential sensitivity of mu ...... s governed by virion exclusion
@nl
Differential sensitivity of mu ...... governed by virion exclusion.
@ast
Differential sensitivity of mu ...... governed by virion exclusion.
@en
Differential sensitivity of mu ...... governed by virion exclusion.
@en-gb
P2093
P2860
P1433
P1476
Differential sensitivity of mu ...... governed by virion exclusion.
@en
P2093
Alexandra Schäfer
Brian P Doehle
Bryan R Cullen
Hal P Bogerd
Heather L Wiegand
P2860
P304
P356
10.1128/JVI.79.13.8201-8207.2005
P407
P577
2005-07-01T00:00:00Z